113 related articles for article (PubMed ID: 37787547)
1. Development and validation of real-time recombinase polymerase amplification-based assays for detecting HPV16 and HPV18 DNA.
Ying J; Mao L; Tang Y; Fassatoui M; Song W; Xu X; Tang X; Li J; Liu H; Jian F; Du Q; Wong G; Feng W; Berthet N
Microbiol Spectr; 2023 Dec; 11(6):e0120723. PubMed ID: 37787547
[TBL] [Abstract][Full Text] [Related]
2. Isothermal Method of a Recombinase Polymerase Amplification Assay for the Detection of Most Common High-Risk Human Papillomavirus Type 16 and Type 18 DNA.
Ma B; Fang J; Wang Y; He H; Dai M; Lin W; Su W; Zhang M
Clin Lab; 2017 Jan; 63(1):27-38. PubMed ID: 28164495
[TBL] [Abstract][Full Text] [Related]
3. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
[TBL] [Abstract][Full Text] [Related]
4. Internally controlled recombinase-aided amplification (IC-RAA) assays for the detection of human papillomavirus genotypes 16 and 18 using extracted DNA and samples treated with nucleic acid releasing agent.
Wang J; Liu J; Song G; Cao Z; Pan J; Li X; Gao Y; Qi J; Chen Z; Fan G; Bai X; Zhang R; Wang R; Duan Q; Li L; Shen X; Ma X
Arch Virol; 2020 Oct; 165(10):2241-2247. PubMed ID: 32681408
[TBL] [Abstract][Full Text] [Related]
5. A novel multiplex real-time PCR assay for the detection and quantification of HPV16/18 and HSV1/2 in cervical cancer screening.
Zhao Y; Cao X; Tang J; Zhou L; Gao Y; Wang J; Zheng Y; Yin S; Wang Y
Mol Cell Probes; 2012 Apr; 26(2):66-72. PubMed ID: 22293505
[TBL] [Abstract][Full Text] [Related]
6. Three-year longitudinal data on the clinical performance of the Abbott RealTime High Risk HPV test in a cervical cancer screening setting.
Poljak M; Oštrbenk A; Seme K; Šterbenc A; Jančar N; Vrtačnik Bokal E
J Clin Virol; 2016 Mar; 76 Suppl 1():S29-S39. PubMed ID: 26643051
[TBL] [Abstract][Full Text] [Related]
7. An integrated isothermal nucleic acid amplification test to detect HPV16 and HPV18 DNA in resource-limited settings.
Kundrod KA; Barra M; Wilkinson A; Smith CA; Natoli ME; Chang MM; Coole JB; Santhanaraj A; Lorenzoni C; Mavume C; Atif H; Montealegre JR; Scheurer ME; Castle PE; Schmeler KM; Richards-Kortum RR
Sci Transl Med; 2023 Jun; 15(701):eabn4768. PubMed ID: 37343083
[TBL] [Abstract][Full Text] [Related]
8. Development of Enzymatic Recombinase Amplification Assays for the Rapid Visual Detection of HPV16/18.
Ding N; Qi W; Wu Z; Zhang Y; Xu R; Lin Q; Zhu J; Zhang H
J Microbiol Biotechnol; 2023 Aug; 33(8):1091-1100. PubMed ID: 37635316
[TBL] [Abstract][Full Text] [Related]
9. Comparison of clinical performances among Roche Cobas HPV, RFMP HPV PapilloTyper and Hybrid Capture 2 assays for detection of high-risk types of human papillomavirus.
Yu S; Kwon MJ; Lee EH; Park H; Woo HY
J Med Virol; 2015 Sep; 87(9):1587-93. PubMed ID: 25914215
[TBL] [Abstract][Full Text] [Related]
10. WarmStart colorimetric LAMP for the specific and rapid detection of HPV16 and HPV18 DNA.
Daskou M; Tsakogiannis D; Dimitriou TG; Amoutzias GD; Mossialos D; Kottaridi C; Gartzonika C; Markoulatos P
J Virol Methods; 2019 Aug; 270():87-94. PubMed ID: 31042552
[TBL] [Abstract][Full Text] [Related]
11. Performance of OncoE6 cervical test with collection methods enabling self-sampling.
Krings A; Dückelmann AM; Moser L; Gollrad J; Wiegerinck M; Schweizer J; Kaufmann AM
BMC Womens Health; 2018 May; 18(1):68. PubMed ID: 29783960
[TBL] [Abstract][Full Text] [Related]
12. HPV16 and HPV18 genotyping in cervical cancer screening.
Ronco G; Franceschi S; Segnan N
Lancet Oncol; 2011 Sep; 12(9):831-2. PubMed ID: 21865085
[No Abstract] [Full Text] [Related]
13. [High-risk HPV genotyping PCR testing as a means of cervical cancer and precancerous lesions early screening].
Ma L; Cong X; Bian M; Shi M; Wang X; Liu J; Liu H
Zhonghua Fu Chan Ke Za Zhi; 2015 Apr; 50(4):246-52. PubMed ID: 26080934
[TBL] [Abstract][Full Text] [Related]
14. [Application of isothermal HPV DNA amplification test in cervical cancer screening].
Wang L; Jiang MY; Qin Y; Li L; Wu ZN; Li TY; Wu T; Chen W
Zhonghua Zhong Liu Za Zhi; 2018 Apr; 40(4):313-318. PubMed ID: 29730922
[No Abstract] [Full Text] [Related]
15. [Performance of human papillomavirus typing test in cervical precancer lesions and cervical cancer screening].
Zhang SK; Luo XP; Li ZF; Su Z; Xia JC; Hu GY; Zhu YJ; Xie LX; Feng XX; Sun XB; Chen W; Qiao YL
Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):252-256. PubMed ID: 32252206
[No Abstract] [Full Text] [Related]
16. Evaluation of the management of Hr-HPV+/PapTest- women: results at 1-year recall.
Chiappetta C; Puggioni C; Lendaro E; Cacciotti J; Zaralli R; Migliore G; Bellardini P; Petrozza V; Della Rocca C; Di Cristofano C
Int J Clin Exp Pathol; 2015; 8(12):16089-96. PubMed ID: 26884886
[TBL] [Abstract][Full Text] [Related]
17. Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody.
Peng S; Ferrall L; Gaillard S; Wang C; Chi WY; Huang CH; Roden RBS; Wu TC; Chang YN; Hung CF
mBio; 2021 Jan; 12(1):. PubMed ID: 33468698
[TBL] [Abstract][Full Text] [Related]
18. The effectiveness of HPV16 and HPV18 genotyping and cytology with different thresholds for the triage of human papillomavirus-based screening on self-collected samples.
Song F; Du H; Wang C; Huang X; Wu R;
PLoS One; 2020; 15(6):e0234518. PubMed ID: 32525936
[TBL] [Abstract][Full Text] [Related]
19. Lower cost strategies for triage of human papillomavirus DNA-positive women.
Qiao YL; Jeronimo J; Zhao FH; Schweizer J; Chen W; Valdez M; Lu P; Zhang X; Kang LN; Bansil P; Paul P; Mahoney C; Berard-Bergery M; Bai P; Peck R; Li J; Chen F; Stoler MH; Castle PE
Int J Cancer; 2014 Jun; 134(12):2891-901. PubMed ID: 24248915
[TBL] [Abstract][Full Text] [Related]
20. The performance of human papillomavirus DNA detection with type 16/18 genotyping by hybrid capture in primary test of cervical cancer screening: a cross-sectional study in 10,669 Chinese women.
Zhao X; Wu Q; Wang X; Fu Y; Zhang X; Tian X; Cheng B; Lu B; Yu X; Lan S; Lu W; Ma D; Cheng X; Xie X
Clin Microbiol Infect; 2018 Dec; 24(12):1322-1327. PubMed ID: 29518562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
